Europe — EMA

Ordspono (Odronextamab)

Odronextamab, the active ingredient in Ordspono, is a unknown presented as a / for use. It treats and in whom. GNH USA supplies Ordspono as a licensed, GDP-compliant international pharmaceutical supplier serving…

Odronextamab

Request sourcing

Pack/s

What is Odronextamab?

Odronextamab, the active ingredient in Ordspono, is a unknown presented as a / for use. It treats and in whom.

GNH USA supplies Ordspono as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

What is Odronextamab used for?

Odronex... (incomplete)

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →